Franke Jennifer, Steinberg Daniel H, Sievert Horst
CardioVascular Center Frankfurt, Frankfurt, Germany.
Minim Invasive Ther Allied Technol. 2009;18(3):110-21. doi: 10.1080/13645700902920486.
Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as standard procedure for atrial septal defect and patent foramen ovale closure. Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement. Until recently, therapy for these diseases was limited to patients in whom severe comorbidities lead to contraindications to surgery. Techniques to treat heart failure caused by left ventricular aneurysms or to prevent cardioembolic stroke by percutaneous occlusion of the left atrial appendage in patients with atrial fibrillation are emerging. This article reviews current indications and recent developments in interventional treatment of structural heart disease.
结构性心脏病的经导管治疗正在迅速发展。由于侵入性较小,经导管技术已取代手术成为房间隔缺损和卵圆孔未闭封堵的标准程序。不断发展的介入技术使得瓣周漏、室间隔缺损及瓣膜置换的治疗成为可能。直到最近,这些疾病的治疗还仅限于那些因严重合并症而导致手术禁忌的患者。治疗左心室动脉瘤引起的心力衰竭或通过经皮封堵房颤患者左心耳来预防心源性栓塞性卒中的技术正在出现。本文综述了结构性心脏病介入治疗的当前适应证和最新进展。